SEKCX
Price
$16.46
Change
+$0.05 (+0.30%)
Updated
Sep 20 closing price
VEMAX
Price
$37.66
Change
-$0.15 (-0.40%)
Updated
Sep 20 closing price
Ad is loading...

SEKCX vs VEMAX

Header iconSEKCX vs VEMAX Comparison
Open Charts SEKCX vs VEMAXBanner chart's image
DWS Emerging Markets Equity C
Price$16.46
Change+$0.05 (+0.30%)
VolumeN/A
CapitalizationN/A
Vanguard Emerging Mkts Stock Idx Adm
Price$37.66
Change-$0.15 (-0.40%)
VolumeN/A
CapitalizationN/A
View a ticker or compare two or three
SEKCX vs VEMAX Comparison Chart
Loading...
VS
SEKCX vs. VEMAX commentary
Sep 21, 2024

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is SEKCX is a Buy and VEMAX is a Sell.

FUNDAMENTALS
Fundamentals
VEMAX has more cash in the bank: 108B vs. SEKCX (68M). VEMAX pays higher dividends than SEKCX: VEMAX (3.43) vs SEKCX (1.23). SEKCX was incepted earlier than VEMAX: SEKCX (23 years) vs VEMAX (18 years). SEKCX is a more actively managed with annual turnover of: 64.00 vs. VEMAX (5.00). SEKCX has a lower initial minimum investment than VEMAX: SEKCX (1000) vs VEMAX (3000). SEKCX (18.08) and VEMAX (17.78) have marching annual gain over last year. VEMAX return over 5 years is better than : 19.71 vs. SEKCX (1.48).
SEKCXVEMAXSEKCX / VEMAX
Total Expense RatioN/AN/A-
Annual Report Gross Expense RatioN/AN/A-
Fund Existence23 years18 years-
Gain YTD9.29610.86686%
Front LoadN/AN/A-
Min. Initial Investment1000300033%
Min. Initial Investment IRAN/AN/A-
Net Assets68M108B0%
Annual Yield % from dividends1.233.4336%
Returns for 1 year18.0817.78102%
Returns for 3 years-14.72-3.34440%
Returns for 5 years1.4819.718%
Returns for 10 years15.3224.3663%
View a ticker or compare two or three
Ad is loading...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
CANG1.610.03
+1.90%
Cango
CAPL21.270.30
+1.43%
CrossAmerica Partners LP
TXNM42.99-0.04
-0.09%
TXNM Energy Inc
CELH33.17-0.90
-2.64%
Celsius Holdings
BIVI2.74-0.09
-3.18%
BioVie Inc